NEW YORK and SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- Nasdaq Private Market (NPM), a leading provider of secondary ...

The determination was made in accordance with Nasdaq Listing Rule 5550 (b) (2), as the market value of the Company's listed ...

Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the "Company”) announced that it received ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) ("CERo” or the "Company”) an innovative immunotherapy company seeking to ...